Take-Two, Lululemon fall; Jazz, BioMarin rise
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday:
Lululemon Athletica Inc., down $6.78 to $348.43.
The athletic apparel maker warned investors that a surge in virus cases hurt its fourth-quarter financial results.
Cardinal Health Inc., down $3.21 to $51.03.
The medical products maker and distributor said supply chain problems will hurt profits for its medical segment in fiscal 2022.
Take-Two Interactive Software Inc., down $21.61 to $142.99.
The maker of “Grand Theft Auto” is buying Zynga, maker of “FarmVille,” in a cash-and-stock deal valued at about $12.7 billion.
Jazz Pharmaceuticals Plc., up $12.06 to $146.49.
The biopharmaceutical company gave investors an encouraging development and financial forecast.
BioMarin Pharmaceutical Inc., up 14 cents to $84.39.
The drug developer reported encouraging results from a study on a potential hemophilia treatment.
Tilly’s Inc., down $1.34 to $14.28.
The clothing and accessories retailer trimmed its financial forecast for the fourth quarter.
Owens & Minor Inc. (OMI), up 27 cents to $45.35.
The health care logistics company is buying Apria for about $1.45 billion.
Halozyme Therapeutics Inc., down $1.30 to $35.99.
Investors were disappointed by the biopharmaceutical company’s financial forecast for fiscal 2022.